img

Global Canine Arthritis Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Canine Arthritis Treatment Market Research Report 2024

The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
According to MRAResearch’s new survey, global Canine Arthritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Canine Arthritis Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Canine Arthritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids

Segment by Application


Veterinary Hospitals and Clinics
Drug Stores
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Canine Arthritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Canine Arthritis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Drug Stores
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Treatment Market Perspective (2018-2033)
2.2 Canine Arthritis Treatment Growth Trends by Region
2.2.1 Global Canine Arthritis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Canine Arthritis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Canine Arthritis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Canine Arthritis Treatment Market Dynamics
2.3.1 Canine Arthritis Treatment Industry Trends
2.3.2 Canine Arthritis Treatment Market Drivers
2.3.3 Canine Arthritis Treatment Market Challenges
2.3.4 Canine Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Treatment Players by Revenue
3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2018-2023)
3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue
3.4 Global Canine Arthritis Treatment Market Concentration Ratio
3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2022
3.5 Canine Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Canine Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Canine Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Treatment Breakdown Data by Type
4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033)
5 Canine Arthritis Treatment Breakdown Data by Application
5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Canine Arthritis Treatment Market Size (2018-2033)
6.2 North America Canine Arthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Canine Arthritis Treatment Market Size by Country (2018-2023)
6.4 North America Canine Arthritis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size (2018-2033)
7.2 Europe Canine Arthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Canine Arthritis Treatment Market Size by Country (2018-2023)
7.4 Europe Canine Arthritis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Canine Arthritis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Arthritis Treatment Market Size (2018-2033)
9.2 Latin America Canine Arthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Canine Arthritis Treatment Market Size by Country (2018-2023)
9.4 Latin America Canine Arthritis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Canine Arthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco (Eli Lilly and Company)
11.1.1 Elanco (Eli Lilly and Company) Company Detail
11.1.2 Elanco (Eli Lilly and Company) Business Overview
11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction
11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2018-2023)
11.1.5 Elanco (Eli Lilly and Company) Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Detail
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction
11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.3.5 Zoetis Inc Recent Development
11.4 Vetoquinol S.A.
11.4.1 Vetoquinol S.A. Company Detail
11.4.2 Vetoquinol S.A. Business Overview
11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction
11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2018-2023)
11.4.5 Vetoquinol S.A. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Canine Arthritis Treatment Introduction
11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2018-2023)
11.5.5 Bayer AG Recent Development
11.6 Aratana Therapeutics Inc
11.6.1 Aratana Therapeutics Inc Company Detail
11.6.2 Aratana Therapeutics Inc Business Overview
11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction
11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.6.5 Aratana Therapeutics Inc Recent Development
11.7 Norbrook Laboratories Limited
11.7.1 Norbrook Laboratories Limited Company Detail
11.7.2 Norbrook Laboratories Limited Business Overview
11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction
11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2018-2023)
11.7.5 Norbrook Laboratories Limited Recent Development
11.8 VetStem Biopharma
11.8.1 VetStem Biopharma Company Detail
11.8.2 VetStem Biopharma Business Overview
11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction
11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2018-2023)
11.8.5 VetStem Biopharma Recent Development
11.9 Dechra Pharmaceuticals Plc
11.9.1 Dechra Pharmaceuticals Plc Company Detail
11.9.2 Dechra Pharmaceuticals Plc Business Overview
11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction
11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2018-2023)
11.9.5 Dechra Pharmaceuticals Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Canine Arthritis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Global Canine Arthritis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Canine Arthritis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Canine Arthritis Treatment Market Share by Region (2018-2023)
Table 8. Global Canine Arthritis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Canine Arthritis Treatment Market Share by Region (2024-2033)
Table 10. Canine Arthritis Treatment Market Trends
Table 11. Canine Arthritis Treatment Market Drivers
Table 12. Canine Arthritis Treatment Market Challenges
Table 13. Canine Arthritis Treatment Market Restraints
Table 14. Global Canine Arthritis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Canine Arthritis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
Table 17. Ranking of Global Top Canine Arthritis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Canine Arthritis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Canine Arthritis Treatment Product Solution and Service
Table 21. Date of Enter into Canine Arthritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Canine Arthritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Canine Arthritis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Canine Arthritis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Canine Arthritis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Canine Arthritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Canine Arthritis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Canine Arthritis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Canine Arthritis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Canine Arthritis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Canine Arthritis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Canine Arthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Canine Arthritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Elanco (Eli Lilly and Company) Company Detail
Table 47. Elanco (Eli Lilly and Company) Business Overview
Table 48. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product
Table 49. Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 50. Elanco (Eli Lilly and Company) Recent Development
Table 51. Boehringer Ingelheim Company Detail
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Canine Arthritis Treatment Product
Table 54. Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Zoetis Inc Company Detail
Table 57. Zoetis Inc Business Overview
Table 58. Zoetis Inc Canine Arthritis Treatment Product
Table 59. Zoetis Inc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 60. Zoetis Inc Recent Development
Table 61. Vetoquinol S.A. Company Detail
Table 62. Vetoquinol S.A. Business Overview
Table 63. Vetoquinol S.A. Canine Arthritis Treatment Product
Table 64. Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 65. Vetoquinol S.A. Recent Development
Table 66. Bayer AG Company Detail
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Canine Arthritis Treatment Product
Table 69. Bayer AG Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Aratana Therapeutics Inc Company Detail
Table 72. Aratana Therapeutics Inc Business Overview
Table 73. Aratana Therapeutics Inc Canine Arthritis Treatment Product
Table 74. Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 75. Aratana Therapeutics Inc Recent Development
Table 76. Norbrook Laboratories Limited Company Detail
Table 77. Norbrook Laboratories Limited Business Overview
Table 78. Norbrook Laboratories Limited Canine Arthritis Treatment Product
Table 79. Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 80. Norbrook Laboratories Limited Recent Development
Table 81. VetStem Biopharma Company Detail
Table 82. VetStem Biopharma Business Overview
Table 83. VetStem Biopharma Canine Arthritis Treatment Product
Table 84. VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 85. VetStem Biopharma Recent Development
Table 86. Dechra Pharmaceuticals Plc Company Detail
Table 87. Dechra Pharmaceuticals Plc Business Overview
Table 88. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product
Table 89. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2018-2023) & (US$ Million)
Table 90. Dechra Pharmaceuticals Plc Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Canine Arthritis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Opioids Features
Figure 5. Global Canine Arthritis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Canine Arthritis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Veterinary Hospitals and Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. E-commerce Case Studies
Figure 10. Canine Arthritis Treatment Report Years Considered
Figure 11. Global Canine Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Canine Arthritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Canine Arthritis Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Canine Arthritis Treatment Market Share by Players in 2022
Figure 15. Global Top Canine Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Canine Arthritis Treatment Revenue in 2022
Figure 17. North America Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 19. United States Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 23. Germany Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Canine Arthritis Treatment Market Share by Region (2018-2033)
Figure 31. China Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Canine Arthritis Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Canine Arthritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Elanco (Eli Lilly and Company) Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 47. Zoetis Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 48. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 49. Bayer AG Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 50. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 51. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 52. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 53. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries